Buprenorphine Hydrochloride 00121-2038-30
- Manufacturer
- Pai Holdings, Llc Dba Pharmaceutical Associates, Inc. And Dba Pai Pharma
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- October 12, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA090622
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
00121-2038-30Selected30 TABLET in 1 BOTTLE (0121-2038-30)